Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Water-Related Injuries |
|
|
Clinical Trial: Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
This study is currently recruiting patients.
Purpose
To study of classical conditioning mechanisms associated with arousal, craving and cocaine use.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders | Drug: Cocaine (IV) | Phase I |
MedlinePlus related topics: Cocaine Abuse
Study Type: Interventional
Study Design: Educational/Counseling/Training, Placebo Control
Official Title: Cocaine Relapse Prevention II
Further Study Details:
Expected Total Enrollment: 16
Study start: September 2004; Expected completion: July 2005
This is a single-site, double-blind, placebo-controlled crossover study of classical conditioning mechanisms associated with arousal, craving and cocaine use.
Eligibility
Ages Eligible for Study: 18 Years - 55 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Be English-speaking volunteers who are cocaine dependent
- Be non-treatment seeking at the time of the study
- Meet DSM-IV criteria for cocaine dependence
- Have ECG showing normal sinus rhythm, normal conductivity, and non clinically significant arrhythmias
- Females must provide a negative pregnancy test and agree to use birth control
- Have baseline laboratory tests within normal limits
Exclusion Criteria:
- Please contact site for more information
Location and Contact Information
John Roache, Ph.D. (210)562-5406 roache@uthscsa.edu
Texas
University of Texas Health Science Center, San Antonio, Texas, 78284, United States; Recruiting
John Roache, Ph.D. 210-562-5406 roache@uthscsa.edu
Study chairs or principal investigators
John Roache, Ph.D., Principal Investigator, University of Texas
More Information
Study ID Numbers: NIDA-CTO-0014-1
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: October 15, 2004
ClinicalTrials.gov Identifier: NCT00094315
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: March 2005
Last Updated: March 24, 2005
Record first received: October 15, 2004
ClinicalTrials.gov Identifier: NCT00094315
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
